Xiamen Beida Zhilubio Engineering

Xiamen Beida Zhilu Biotechnology, a core subsidiary of the Sinobioway Group, is a prominent Chinese biopharmaceutical company specializing in the development and commercialization of neurotrophic factors. The company is best known for its flagship product, Enjingfu (Mouse Nerve Growth Factor for Injection), which was the first nerve growth factor drug approved globally for clinical use. Based in Xiamen, the company operates large-scale GMP-certified manufacturing facilities for recombinant proteins and biological products. Its business model focuses on the R&D of innovative biologics for neurological repair and the treatment of nerve-related injuries.